Skip to main content
Clinical Trials/CTRI/2022/02/039995
CTRI/2022/02/039995
Not yet recruiting
未知

Comparative clinical study to evaluate efficacy of Amritadi Guggulu and Vyoshadi Guggulu after Virechana in the management of Medoroga(Dyslipidemia)

All India Institute Of Ayurveda0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: E785- Hyperlipidemia, unspecified
Sponsor
All India Institute Of Ayurveda
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patient with Pratyatma Lakshan of Medoroga
  • Patient fulfilling the Diagnostic Criteria of Dyslipidemia
  • Patients of Age group between 21 to 50 years irrespective of gender, caste, creed and body weight
  • Patients fit for Virechana karma
  • Patient willing and able to give written consent in the study

Exclusion Criteria

  • Patients with poorly controlled Diabetes Mellitus (HbA1c \>10%) and Hypertension ( BP \> 160 / 100 mm Hg)
  • Pregnant / lactating woman
  • Patients with genetic syndromes, severe cardiovascular disease or any other life threatening condition.
  • History of hypersensitivity to any of the trial drugs or their ingredients.
  • Patients unfit for Virechana karma
  • Patients having systemic illness which will interfere with the course of procedure.
  • Patients who are already enrolled in other study.

Outcomes

Primary Outcomes

Not specified

Similar Trials